Clario vs Medable(eCOA)

Sponsors, CROs and academic research teams choosing an eCOA platform for a regulated clinical trial.

Scope Electronic clinical outcome assessment (eCOA) platforms that capture patient-reported (ePRO), clinician-reported, observer-reported and performance outcomes in regulated clinical trials, as a sponsor, CRO or academic research team would shortlist them.

Guide updated How we compare

Compare within eCOA

Study fit, side by side

These notes describe the products in the eCOA guide.

Clario

Best for
Global pivotal trials that combine eCOA with cardiac, respiratory, imaging or sensor endpoints
What to consider
Clario has the deepest enterprise eCOA profile here: studies in 120+ countries and 100+ languages, a named eCOA science team and pre-validated assessment libraries. It says it has supported 70% of FDA and EMA new drug approvals since 2015 across its endpoints. Builds are delivered by Clario and prices are not published.
Read product profile

Medable

Best for
Sponsors and CROs that want a no-code eCOA build tool with eConsent and televisits on one platform
What to consider
Medable pairs a large library (400+ validated instruments, 120+ locales) with Study Studio, a no-code builder its site says takes studies live in 4 to 6 weeks. It publishes Part 11, Annex 11, HIPAA and GDPR compliance but no regulatory approval counts or prices.
Read product profile

Compare the features

Both products use the same category definitions. Product order is editorial; products are not ranked.

Full eCOA feature comparison

Single and double checks describe documented support for an individual feature. Double checks use the extended definition for that feature. Unknown means the available evidence does not establish support.

Expand a feature definition or support note for context and its original source.

Clario vs Medable (eCOA): category feature evidence and sources. Products are not ranked.
Category featureClarioMedable
Validated instrument library and licensing
Feature definitions
Supported
A library of outcome-assessment instruments is documented.
Extended support
A validated or instrument-author-approved library plus managed instrument licensing are documented.
Supported

Pre-built, validated assessment libraries, the Rapid Start assessment catalog and an eCOA Science Services team with named scientists.

Source
About this support label

Validated libraries and science services are documented; managed licensing is not established.

Supported

400+ pre-built, validated instruments in a reusable library with AI-assisted instrument generation; licensing services are not described on the pages checked.

Source
About this support label

A validated library is documented; licensing services are not described.

Regulatory compliance and track record
Feature definitions
Supported
Relevant trial or security controls are stated.
Extended support
Relevant trial controls plus a public ISO/SOC certificate or audit report are documented; a certification claim or logo alone is insufficient.
Supported

States it has supported 70% of FDA and EMA new drug approvals since 2015 (company-wide, all endpoint types); ISO 27001:2022 and SOC 2 Type II are published separately.

Source
About this support label

ISO/SOC certifications are stated; this note does not establish a public certificate or audit report.

Supported

States compliance with 21 CFR Part 11, Annex 11, HIPAA, GDPR and ICH GCP and says its eCOA data can support primary endpoints in pivotal studies; deployed in nearly 400 trials, with no approval counts published.

Source
Global scale and languages
Feature definitions
Supported
Multicountry use or multilingual/localized participant support is documented.
Extended support
Both multicountry use and multilingual/localized participant support are documented.
Extended support

Studies in over 120 countries and over 100 languages; 25 years of DCT and hybrid trials.

Source
About this support label

The note reports studies across countries and languages.

Extended support

80+ countries and 120+ locales; device logistics from six global depots to 65+ countries.

Source
About this support label

The note documents deployment across countries and localized participant support.

Capture modes and integrations
Feature definitions
Supported
Electronic outcome capture and a connection to another trial system or device are documented.
Extended support
Capture on participant-owned and provisioned devices plus wearable or sensor integration are documented.
Extended support

BYOD, web or provisioned devices, plus pre-validated connected devices (CGM, glucose meters, Opal motion sensors) integrated with the eCOA device.

Source
About this support label

BYOD and provisioned devices are offered with integrated, pre-validated connected devices.

Extended support

eCOA, eConsent, TeleVisit and devices in one platform, BYOD or provisioned, with sensors and connectors to other clinical systems.

Source
About this support label

BYOD and provisioned devices are documented alongside sensors and clinical-system connectors.

Time to launch and self-service build
Feature definitions
Supported
A study build process, self-service builder or launch timeframe is documented.
Extended support
Study teams can configure the study themselves, with a stated build or launch timeframe.
Supported

eCOA Swift deploys early-phase oncology trials in as little as 2 weeks and Rapid Start offers pre-configured assessments; builds are vendor-delivered, no self-service designer published.

Source
About this support label

Vendor-delivered oncology deployment timing is stated; a self-service designer is not documented.

Supported

Study Studio is a no-code visual builder; studies that took 16 to 20 weeks go live in 4 to 6 weeks, some in a day.

Source
About this support label

A no-code builder and launch timing are documented; study-team self-service is not explicit.

Published pricing and terms
Feature definitions
Supported
A production pricing basis, model or contract terms beyond a sales contact are published.
Extended support
Numerical production prices or a free production option with its conditions are published.
Unknown

Not published: no price, pricing model or contract terms on the vendor site; pricing by sales contact only.

Source
About this support label

Sales contact alone does not establish a published pricing model, prices or contract terms.

Unknown does not mean unavailable. The public evidence does not establish support under this category’s definition.

Supported

Platform prices not published; device provisioning is described as one all-inclusive monthly rate, without an amount.

Source
About this support label

A monthly device-provisioning model is described; platform prices are not published.

The guide update date reflects guide edits. Vendor statements are attributed in the evidence.

Keep the category in view

Compare these products with the other tools in the eCOA guide using the same feature definitions.

More eCOA comparisons featuring one of these products.